College of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA.
Division of Health Policy and Research, Nkafu Policy Institute, Yaoundé, Cameroon; Department of Public Health, University of Buea, Cameroon; Faculty of Health Science, University of Buea, Cameroon.
Am J Surg. 2023 Oct;226(4):409-421. doi: 10.1016/j.amjsurg.2023.03.013. Epub 2023 Mar 27.
Management of acute, post-operative, and chronic pain requires access to and availability of opioids. While often oversupplied in high-income countries, significant shortages exist in low- and middle-income countries. We conducted a scoping review on availability and usage of opioids in Sub-Saharan Africa (SSA).
The five-stage approach of Arksey and O'Malley (2005) was used. MEDLINE via PubMed, EMBASE, and SCOPUS were search and results categorized into themes: 1) Local/regional availability and supply, 2) Consumption patterns, 3) Legislation and policy, 4) Costs and financing, 5) Knowledge and cultural beliefs, and 6) Education and training.
6923 studies were identified from which 69 (1%) met inclusion criteria. Five key findings were: 1) Significant shortages exist, especially in rural areas, 2) Non-opioid analgesics commonly used as first-line acute pain management, 3) Barriers to market entry and bureaucratic processes prevent local production, 4) Significant knowledge gaps/myths exist amongst healthcare practitioners on opioid use, and 5) Continuous education and short courses will be critical.
Major challenges significantly limit availability and utilization of essential opioids in SSA. Reforms needed to upscale training and education, increase uptake by professionals, and increase market entry.
急性、术后和慢性疼痛的管理需要获得和提供阿片类药物。虽然在高收入国家往往供应过剩,但中低收入国家存在着严重的短缺。我们对撒哈拉以南非洲(SSA)阿片类药物的可及性和使用情况进行了范围界定审查。
采用 Arksey 和 O'Malley(2005)的五阶段方法。通过 MEDLINE 中的 PubMed、EMBASE 和 SCOPUS 进行搜索,并将结果分为主题:1)当地/区域的可及性和供应;2)消费模式;3)立法和政策;4)成本和融资;5)知识和文化信仰;6)教育和培训。
从 6923 项研究中确定了 69 项(1%)符合纳入标准。有五项主要发现:1)存在严重短缺,特别是在农村地区;2)非阿片类镇痛药通常用作急性疼痛管理的一线药物;3)市场准入和官僚程序的障碍阻碍了当地生产;4)卫生保健从业者在阿片类药物使用方面存在重大知识差距/误解;5)持续的教育和短期课程将是关键。
重大挑战严重限制了 SSA 基本阿片类药物的可及性和利用。需要改革以扩大培训和教育、提高专业人员的接受程度以及增加市场准入。